GlassScriptPhysician profile
Sara Cooke
NPI 1174119820
$9,711.74
in general payments reported to CMS, 2019-2025
68 companies · $2,145 in 2025
The $2,145 reported for 2025 was more than what 94% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,201 · 2023: $2,646 · 2024: $3,720 · 2025: $2,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,500 · Education: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,499.61 |
| Education | $1,010.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $890.50 | 2022-2025 | |
| Janssen Biotech, INC. | $738.64 | 2022-2025 | Darzalex, Tecvayli, Rybrevant |
| Lilly USA, LLC | $612.75 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Daiichi Sankyo INC. | $575.45 | 2022-2025 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $502.38 | 2022-2025 | Enhertu, Imfinzi, Lynparza |
| Seagen INC. | $458.34 | 2022-2023 | Adcetris, Tivdak, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $407.85 | 2022-2025 | |
| Pfizer INC. | $360.26 | 2022-2025 | |
| Sobi, INC | $308.08 | 2022-2025 | |
| Incyte Corporation | $307.34 | 2022-2025 | Jakafi, Monjuvi |
| Takeda Pharmaceuticals U.S.A., INC. | $302.74 | 2023-2025 | Fruzaqla, Iclusig, Alunbrig |
| Celgene Corporation | $287.39 | 2022-2025 | Reblozyl, Pomalyst |
| Eisai INC. | $274.84 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $272.62 | 2022-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $271.76 | 2022-2025 | Keytruda, Lynparza |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Cooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.